Introduction: Decellularized larynges could be used as scaffolds to regenerate the larynx. The purpose of this study was to establish a perfusion decellularization protocol to produce a 3-dimensional whole laryngeal extracellular matrix (ECM) scaffold in a rabbit model. Methods: The larynges of 20 rabbits assigned to the study group were harvested and decellularized using a perfusion decellularization protocol, while the larynges of 10 rabbits in the control group were harvested and untreated. Macroscopic and microscopic morphological analyses, a molecular analysis, a cellular content analysis, and scanning electron microscopy were performed. Results: A histological analysis showed the absence of cellular components, the presence of the ECM, and an intact cartilage structure filled with chondrocytes. The mean total DNA amounts of the native larynx, decellularized larynx, and decellularized cartilage-free larynx were 1,826.40, 434.70, and 41.40 μg/µL, respectively; those for the decellularized larynx and decellularized cartilage-free larynx were significantly lower (p < 0.001 and p < 0.001, respectively). The total amount of DNA in the decellularized sample was significantly lower compared to that in the native sample, at 57.2% in cartilage (p < 0.001), 2.4% in the thyroid gland (p < 0.001), 2.7% in muscle (p < 0.001), 1.6% in vessels (p < 0.001), and 4.8% in the vocal cords (p < 0.001). Conclusion: Our perfusion decellularization protocol is feasible and reproducible to produce a 3-dimensional whole laryngeal ECM scaffold in a rabbit.

1.
Strome
M
,
Stein
J
,
Esclamado
R
,
Hicks
D
,
Lorenz
RR
,
Braun
W
,
Laryngeal transplantation and 40-month follow-up
.
N Engl J Med
.
2001
;
344
(
22
):
1676
9
. .
2.
Farwell
DG
,
Birchall
MA
,
Macchiarini
P
,
Luu
QC
,
de Mattos
AM
,
Gallay
BJ
,
Laryngotracheal transplantation: technical modifications and functional outcomes
.
Laryngoscope
.
2013
;
123
(
10
):
2502
8
. .
3.
Krishnan
G
,
Du
C
,
Fishman
JM
,
Foreman
A
,
Lott
DG
,
Farwell
G
,
The current status of human laryngeal transplantation in 2017: a state of the field review
.
Laryngoscope
.
2017
;
127
(
8
):
1861
8
. .
4.
Baiguera
S
,
Gonfiotti
A
,
Jaus
M
,
Comin
CE
,
Paglierani
M
,
Del Gaudio
C
,
Development of bioengineered human larynx
.
Biomaterials
.
2011
;
32
(
19
):
4433
42
. .
5.
Ma
R
,
Li
M
,
Luo
J
,
Yu
H
,
Sun
Y
,
Cheng
S
,
Structural integrity, ECM components and immunogenicity of decellularized laryngeal scaffold with preserved cartilage
.
Biomaterials
.
2013
;
34
(
7
):
1790
8
. .
6.
Langer
R
,
Vacanti
JP
.
Tissue engineering
.
Science
.
1993
;
260
(
5110
):
920
6
. .
7.
Gilbert
TW
,
Sellaro
TL
,
Badylak
SF
.
Decellularization of tissues and organs
.
Biomaterials
.
2006
;
27
(
19
):
3675
83
. .
8.
Badylak
SF
,
Freytes
DO
,
Gilbert
TW
.
Extracellular matrix as a biological scaffold material: structure and function
.
Acta Biomater
.
2009
;
5
(
1
):
1
13
. .
9.
Lu
TY
,
Lin
B
,
Kim
J
,
Sullivan
M
,
Tobita
K
,
Salama
G
,
Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells
.
Nat Commun
.
2013
;
4
:
2307
. .
10.
Lynch
AP
,
Ahearne
M
.
Strategies for developing decellularized corneal scaffolds
.
Exp Eye Res
.
2013
;
108
:
42
7
. .
11.
Mercuri
JJ
,
Patnaik
S
,
Dion
G
,
Gill
SS
,
Liao
J
,
Simionescu
DT
.
Regenerative potential of decellularized porcine nucleus pulposus hydrogel scaffolds: stem cell differentiation, matrix remodeling, and biocompatibility studies
.
Tissue Eng Part A
.
2013
;
19
(
7–8
):
952
66
. .
12.
Song
JJ
,
Ott
HC
.
Organ engineering based on decellularized matrix scaffolds
.
Trends Mol Med
.
2011
;
17
(
8
):
424
32
. .
13.
Ott
HC
,
Matthiesen
TS
,
Goh
SK
,
Black
LD
,
Kren
SM
,
Netoff
TI
,
Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart
.
Nat Med
.
2008
;
14
(
2
):
213
21
. .
14.
Goh
SK
,
Bertera
S
,
Olsen
P
,
Candiello
JE
,
Halfter
W
,
Uechi
G
,
Perfusion-decellularized pancreas as a natural 3D scaffold for pancreatic tissue and whole organ engineering
.
Biomaterials
.
2013
;
34
(
28
):
6760
72
. .
15.
Mirmalek-Sani
SH
,
Orlando
G
,
McQuilling
JP
,
Pareta
R
,
Mack
DL
,
Salvatori
M
,
Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering
.
Biomaterials
.
2013
;
34
(
22
):
5488
95
. .
16.
Song
JJ
,
Guyette
JP
,
Gilpin
SE
,
Gonzalez
G
,
Vacanti
JP
,
Ott
HC
.
Regeneration and experimental orthotopic transplantation of a bioengineered kidney
.
Nat Med
.
2013
;
19
(
5
):
646
51
. .
17.
Shipchandler
TZ
,
Lott
DG
,
Lorenz
RR
,
Friedman
AD
,
Dan
O
,
Strome
M
.
New mouse model for studying laryngeal transplantation
.
Ann Otol Rhinol Laryngol
.
2009
;
118
(
6
):
465
8
. .
18.
Lorenz
RR
,
Dan
O
,
Fritz
MA
,
Nelson
M
,
Strome
M
.
Rat laryngeal transplant model: technical advancements and a redefined rejection grading system
.
Ann Otol Rhinol Laryngol
.
2002
;
111
(
12 Pt 1
):
1120
7
. .
19.
Strome
S
,
Sloman-Moll
E
,
Samonte
BR
,
Wu
J
,
Strome
M
.
Rat model for a vascularized laryngeal allograft
.
Ann Otol Rhinol Laryngol
.
1992
;
101
(
11
):
950
3
. .
20.
Hou
N
,
Cui
P
,
Luo
J
,
Ma
R
,
Zhu
L
.
Tissue-engineered larynx using perfusion-decellularized technique and mesenchymal stem cells in a rabbit model
.
Acta Otolaryngol
.
2011
;
131
(
6
):
645
52
. .
21.
Bhosale
AM
,
Richardson
JB
.
Articular cartilage: structure, injuries and review of management
.
Br Med Bull
.
2008
;
87
:
77
95
. .
22.
Wang
EC
,
Damrose
EJ
,
Mendelsohn
AH
,
Nelson
SD
,
Shintaku
IP
,
Ye
M
,
Distribution of class I and II human leukocyte antigens in the larynx
.
Otolaryngol Head Neck Surg
.
2006
;
134
(
2
):
280
7
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.